In the absence of vaccines, many scientists argue that the best approach to control the spread of the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2) would be fast, cheap, reliable, and portable means of diagnosing COVID-19 infection. In particular, the identification of patients with the highest risk of COVID-19 mortality (i.e. those with co-morbidities such as cardiovascular disorders or massive alveolar damage and progressive respiratory failure) could significantly improve the capacity of healthcare providers to take early action and minimize the possibility of overwhelming care centers, which in turn would save many lives.
Researchers use plasmonics to enhance fluorescent markers in lab-on-a-chip diagnostic devices.
Researchers have designed and demonstrated a new type of technology based on 2D semiconducting materials that's almost as energy-efficient as the human brain.
Researchers develop a new way to create 3D scaffolds for biomedical applications.
Novel technology allows for the simultaneous imaging of multiple proteins in a single cell.
Researchers are developing safe, new anti-viral nanoparticle coatings that demonstrate significant potential in preventing active surface infection with SARS-CoV-2.
This is the first time that 2D material properties have been linked to specific defects in the materials' crystal structure. This approach enables systematic defect engineering in 2D materials.
Researchers capture crystal Nnucleation with atomic resolution in 4D (3D plus time).